Zacks.com on MSN

Astera Labs, Inc. (ALAB) Stock Dips While Market Gains: Key Facts

Astera Labs, Inc. (ALAB) reached $168.83 at the closing of the latest trading day, reflecting a -2.2% change compared to its last close.

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...